Regulation of the Gene-Encoding Angiotensin II Receptor in Vascular Tissue

References

• Catt K J, Mendelsohn F AC, Millan M A, Aguilera G. The role of angiotensin II receptors in vascular regulation. J Cardiovasc Pharmacol 1984; 6: S575
   Web of Science ®Google Scholar
• Chang R SL, Lotti V J. Angiotensin receptor subtypes in rat, rabbit and monkey tissues: relative distribution and species dependency. Life Sci 1991; 49: 1485
   PubMedGoogle Scholar
• Chiu A T, Carini D J, Johnson A L, McCall D E, Price W A, Thoolen M JMC, Wong P C, Taber R I, Timmermans P BMWM. Non-peptide angiotensin II receptor antagonists. II. Pharmacology of S-8303. Eur J Pharmacol 1988; 157: 13
   PubMed Web of Science ®Google Scholar
• Chiu A T, Duncia J V, McCall D E, Wong P C, Price W A, Thoolen M JMC, Carini D J, Johnson A L, Timmermans P BMWM. Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies. J Pharmacol Exp Ther 1989; 250: 867
   PubMed Web of Science ®Google Scholar
• Criscione L, Thomann H, Whitebread S, de Gasparo M, Buhlmayer P, Herold P, Ostermayer F, Kamber B. Binding characteristics and vascular effects of various angiotensin II mantagonists. J Cardiovasc Pharmacol 1990; 16(Suppl 4)S56
   PubMedGoogle Scholar
• De Gasparo M, Whitebread S, Mele M, Motani A S, Whitcombe P J, Ramjoue H P, Kamber B. Biochemical characterization of two angiotensin II receptor subtypes in the rat. J Cardiovasc Pharmacol 1990; 16(Suppl 4)S31
   Google Scholar
• Devynck M A, Meyer P. Angiotensin receptors in vascular tissue. Am J Med 1976; 61: 758–767
   PubMed Web of Science ®Google Scholar
• Edwards R M, Aiyar N, Ohlstein E H, Weidley E F, Griffin E, Ezekiel M, Keenan R M, Ruffolo R R, Weinstock J. Pharmacological characterization of the nonpepetide angiotensin II receptor antagonist, SK&F 108566. J Pharmacological Exp Ther 1992; 260: 175
   PubMed Web of Science ®Google Scholar
• Gilson R E, Thorpe H H, Cartwright M E, Frank J D, Schorn T W, Bunting P B, Siegl P KS. Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkey. Am J Physiol 1991; 261: F512
   Google Scholar
• Grone H J, Simon M, Fuchs E. Autoradiographic characterization of angiotensin receptor subtypes in fetal and adult human kidney. Am J Physiol 1992; 262: F326
   Google Scholar
• Gunther S, Gimbrone M A, Alexander R W. Regulation by angiotensin of its receptors in resistance blood vessels. Nature 1980; 287(18): 230–232
   Google Scholar
• Liorens-Cortes C, Greenberg B, Huang H M, Corvol P. Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension 1994; 24: 538–548
   Google Scholar
• Owens G K. Role of contractile agonists in growth regulation of vascular smooth muscle cells. Cellular and Molecular Mechanisms in Hypertension, R H Cox. Plenum Publishers, New York 1991; 71–79
   Google Scholar
• Prewitt R L, Wang D H, Hill M A. Hypertension. The Pathophysiology of the Microcirculation, N A Mortillaro, A E Taylor. Florida. CRC Press, Inc. 1994; 61–86
   Google Scholar
• Prewitt R L, Wang D H, Nakamura T, Smith E G. Growth and modification in number of resistance vessels. The Resistance Vasculature, J A Bevan, W Halpern, M Mulvany. Humana Press, Inc., Clifton, NJ. 1991; 127–142
   Google Scholar
• Wang D H, Prewitt R L. Captorpril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension 1990; 15: 68–77
   PubMed Web of Science ®Google Scholar
• Wang D H, Prewitt R L. Longitudinal study of captopril on aortic and arteriolar development in normotensive rats. Am J Physiol 1991; 260(6)H1959–H1956
   Google Scholar
• Wang D H, Prewitt R L, Beebe S J. Regulation of PDGF A: A possible mechanism for angiotensin II induced vascular growth. Am J Physiol 1995; 269(38)H356–H364
   Google Scholar
• Whitebread S, Mele M, Kamber B, De Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Comm 1989; 163: 284
   PubMed Web of Science ®Google Scholar
• Wong P C, Chiu A T, Price W A, Thoolen M JMC, Carini D J, Johnson A L, Taber R I, Timmermans P BMWM. Nonpeptide angiotensin II receptor antagonists. I Pharmacological characterization of 2-n-butyl-4-chloro-1-(2-chlorobenzyl)imidazole-5-acetic acid, sodium salt (S-8307). J Pharmacol Exp Ther 1988; 247: 1
   PubMed Web of Science ®Google Scholar
• Wong P C, Price W A, Chiu A T, Duncia J V, Carini D J, Wexler R R, Johnson A L, Timmermans P BMWM. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP753, an orally active antihypertensive agent. J Pharmacol Exp Ther 1990; 252: 719
   PubMed Web of Science ®Google Scholar
• Wong P C, Price W A, Chiu A T, Thoolen M JMC, Duncia J V, Johnson A L, Timmermans P BMWM. Nonpeptide angiotensin II receptor antagonists. IV. EXP6155 and EXP6803. Hypertension 1989; 13: 489
   PubMedGoogle Scholar